Navigation Links
Terminolgy matters in parents' willingness to enroll their children in research

(Garrison, NY) When presented with different terms to describe a clinical trial, parents were far more likely to consent to enroll their child if it was called a "research study" than if it was called a "medical experiment" or a "research project," in large part because they perceived the former as safer, even though that was not necessarily the case, according to a report in IRB: Ethics & Human Research.

Terms such as these are typically used interchangeably in informed consent forms and by researchers describing trials to potential participants and their parents, on the assumption that they mean the same thing. However, parents interpret the terms differently, suggesting that standard descriptions used in informed consent include "information that potentially biases how a parent receives the invitation to participate," the researchers conclude.

For the study, 94 parents who had taken a child to the emergency department at the Children's Hospital of Pittsburgh answered six questions that assessed their willingness to enroll their child in a study and their perception of the following protocol descriptions: research study, research project, research experiment, medical experiment, and medical study.

Only 18 percent of the parents thought these terms were equivalent. Of the parents who did not think the terms meant the same thing, most would allow their child to participate in a "research study" but not in a "research project," a "medical study," or a "medical experiment." The parents also identified the words "medical" and "experiment" as having negative connotations.

The researchers conclude that "approximately 63% of the respondents rated the protocol descriptors as being different with respect to protocol risk and safety and the inclusion of untested treatments, procedures, and medicines." To minimize bias, the researchers suggest that consent forms use value-free descriptions about research and include a glossary of terms. In addition, they recommend that institutional review boards carefully scrutinize the language in consent forms to ensure that semantic biases are not imbedded in them.


Contact: Susan Gilbert
845-424-4040 x244
The Hastings Center

Related medicine news :

1. Shape matters: The corkscrew twist of H. pylori enables it to set up shop in the stomach
2. Size matters -- when it comes to DNA
3. Reproductive health matters addresses issues related to cosmetic surgery, body image and sexuality
4. Education matters: Study of womens health insurance links education to coverage
5. Therapist competence matters -- and more for some patients than others
6. Dads Family History of Breast, Ovarian Cancer Matters, Too
7. Breast Cancer Outcome: Your Doctor Matters
8. Explorers Bounty Puffed Fruit Snacks Helping Parents Battle Summer Obesity
9. Parents often wait too long to treat childrens asthma symptoms
10. New intervention helps Latino parents of asthmatic children quit smoking
11. PDA Reminds Parents About the Importance of Childrens Oral Health
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... For many X-rays taken ... for accurate interpretation by the radiologist. The marking utensils are so small, however, ... has found a way to alleviate this problem. , He developed the patent-pending ...
(Date:12/1/2015)... ... December 01, 2015 , ... Visage accelerates ... a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced they ... Society of North America (RSNA) 2015 annual meeting through December 3 in Chicago, ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next ... selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an ... was recognized as a finalist in the category of Digital Solutions for its ...
(Date:12/1/2015)... ... ... Lutronic, a leading innovator of aesthetic and medical laser and energy-based technology, announced ... the United States. Clarity is a Superior Dual Wavelength Platform which combines two ... platform that is easy to own and operate. , For over a decade, ...
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s ... Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning healthcare ... once a deal is signed. This quick-read guidance suggests that failing to ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 01, 2015 ... addition of the "2016 Europe ... E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, ... their offering. --> ... the "2016 Europe Enteric Disease ...
(Date:12/1/2015)... -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing ... that the company will present at the LD Micro Main ... Luxe Sunset Boulevard Hotel in Los Angeles, CA. ... will present on Thursday, December 3, at 9:00 am Pacific ... register at least 10 minutes prior to the start of ...
(Date:12/1/2015)... CytRx Corporation (NASDAQ: CYTR ), a ... announced that it has reached its enrollment target of ... clinical trial of aldoxorubicin in patients with previously treated ... completed in Q1 2016. The Phase 3 trial is a ... Assessment from the FDA at 79 sites in ...
Breaking Medicine Technology: